详细信息
前列舒宁对丙酸睾丸酮所致前列腺增生的抑制作用研究 被引量:2
Study on Qianlieshuning (前列舒宁) Tablet's restraining prostate hyperplasia caused by testosterone propionate
文献类型:期刊文献
中文题名:前列舒宁对丙酸睾丸酮所致前列腺增生的抑制作用研究
英文题名:Study on Qianlieshuning (前列舒宁) Tablet's restraining prostate hyperplasia caused by testosterone propionate
作者:马骏[1];任远[1];金辉[1];姜晓霞[1]
第一作者:马骏
机构:[1]甘肃中医学院中药系,兰州730000
第一机构:甘肃中医药大学药学院(西北中藏药协同创新中心办公室)
年份:2002
卷号:18
期号:3
起止页码:32
中文期刊名:中药药理与临床
外文期刊名:Pharmacology and Clinics of Chinese Materia Medica
收录:CSCD:【CSCD_E2011_2012】;
语种:中文
中文关键词:前列舒宁;丙酸睾丸酮;前列腺增生;抑制作用
外文关键词:QLSN tablet;prostate hyperplasia
摘要:目的 :观察前列舒宁抗前列腺增生作用。方法 :皮下注射丙酸睾丸酮 ,制造大、小鼠前列腺增生模型 ,观察前列腺湿重及前列腺指数 ,并进行组织学检查。结果 :对丙酸睾丸酮所致前列腺增生 ,前列舒宁能显著减轻前列腺湿重、减少前列腺指数 ,病理组织学检查也显示前列舒宁对前列腺增生有明显抑制作用。结论
Objective: To study the effect of Qianlieshuning tablet's (QLSN) restraining prostate hyperplasia. Methods: To hypodermically inject testosterone propionate, and to produce the models of rats' and mice's prostate hyperplasia in order to observe the weight and the index of the prostate; to carry out the pathological examination. Results: QLSN tablet can evidently reduce the weight and the index of the prostate, and the pathological examination also shows that QLSN tablet can distinctly restrain the prostate hyperplasia. Conclusion: QLSN tablet can evidently restrain the prostate hyperplasia.
参考文献:
正在载入数据...